STOCK TITAN

Opgen SEC Filings

CFOR OTC Link
Rhea-AI Summary

CapForce Inc. filed a Form 12b-25 notifying the SEC that it cannot timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 without unreasonable effort or expense. The delay stems from valuation and purchase price allocation work related to the company’s previously disclosed acquisition of iCapX Sdn. Bhd. and limited internal accounting resources. The company is completing its financial close and expects its Annual Report on Form 10-K for the year ended December 31, 2025 remains in process; the filing states the company anticipates significant changes in results for the quarter versus the prior-year period.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

CapForce Inc. filed a Form 12b-25 Notification of Late Filing stating it cannot timely file its Annual Report on Form 10-K for the period ended December 31, 2025. The delay is attributed to valuation and purchase price allocation work related to the previously disclosed acquisition of iCapX Sdn. Bhd. and limited internal accounting personnel. The company expects to file the Form 10-K within the fifteen calendar day extension permitted by Rule 12b-25.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many Opgen (CFOR) SEC filings are available on StockTitan?

StockTitan tracks 2 SEC filings for Opgen (CFOR), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Opgen (CFOR)?

The most recent SEC filing for Opgen (CFOR) was filed on May 15, 2026.